The next era in discovering drugs in nature's own medicine cabinet

September 4, 2013

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Lisa M. Jarvis, C&EN senior editor, points out that natural products are the source of about half of the modern drugs approved in the U.S. But the search for new products slowed as drug companies learned to make synthetic compounds at high speeds by the thousands. Now, the increasing availability and affordability of DNA sequencing is reviving activity in the field. It enables scientists to sample the DNA of thousands of microbes at once in search of gene clusters that could yield a new drug. Then computer models can figure out what molecules the genes encode, and organize the information in searchable databases.

The potential for discovering new medicines is high enough to attract the attention—and millions of dollars in investments—of some of the pharmaceutical industry's major players, including Sanofi and Novartis. The article notes that the latest research has significantly increased the number of microbial compounds being discovered and has opened a window on a vast new library of genes and gene clusters that code for previously undiscovered drugs. The flood of genetic discovery underpins expectations that potential new medicines based on natural products will be in clinical trials in humans within a few years.

Explore further: Not by DNA alone: How the epigenetics revolution is fostering new medicines

More information: "Nature's Second Act" cen.acs.org/articles/91/i35/Na … ures-Second-Act.html

Related Stories

Chemical company giants stall with global economy

July 31, 2013

The world's 50 largest chemical companies—with combined 2012 sales of almost $1 trillion and products that touch the lives of people everywhere—are the topic of the cover story in the current edition of Chemical & Engineering ...

Microdosing: Updating its role in developing new medicines

January 23, 2013

One of yesterday's most promising new tools for speeding the development of new medicines—"microdosing"—has found niches in that process today, and they include uses unanticipated a decade ago. That topic, an update on ...

Renewed hope in a once-abandoned cancer drug class

June 19, 2013

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments for ovarian and ...

Preventing cancer, quite naturally

June 23, 2010

Exciting headlines about the cancer-preventing potential of berries, red wine, and other foods are in the news almost every day. An article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine, ...

Recommended for you

Bioluminescent worm found to have iron superpowers

December 14, 2017

Researchers at Scripps Institution of Oceanography at the University of California San Diego have made a discovery with potential human health impacts in a parchment tubeworm, the marine invertebrate Chaetopterus sp., that ...

Scientists develop new, rapid pipeline for antimicrobials

December 14, 2017

With hospitals more often reaching for antibiotics of last resort to fight infections and recent Ebola and Zika outbreaks crossing borders like never before, the worldwide scientific community has been challenged with developing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.